Patients' preferences for systemic treatment of atopic dermatitis

Participants attached great importance to safety and symptom control. However, preferences were also dependent on individual characteristics ...

To investigate preferences of patients with AD for attributes of currently approved systemic treatments and assess influencing factors.

Patient Preferences in the Treatment of Moderate-to-severe Atopic ...

A variety of systemic treatments are available for patients with moderate-to-severe atopic dermatitis. This study found that avoiding risk of severe adverse ...

Patients' preferences for systemic treatment of atopic dermatitis

The advent of biologics and janus kinase inhibitors has revolutionized treatment of atopic dermatitis (AD). Objective. To investigate preferences of patients ...

Patient preferences for atopic dermatitis treatment profiles: results ...

Topical treatments were currently used by 78%, whilst 42% used oral, and 13% injectable. One-third (34%) had experience (currently or previously) ...

Assessing Patient Preferences for Atopic Dermatitis Treatment

Corticosteroids, calcineurin inhibitors, phosphodiesterase-4 inhibitors, and other topical immunosuppressants are first-line pharmacotherapies ...

Patient preferences for atopic dermatitis treatments: a discrete ...

Systemic therapies are recommended for patients with more severe forms of AD if their symptoms are not adequately controlled with topical ...

Incorporating Patient Preferences in the Treatment of Atopic Dermatitis

A panel of experts on atopic dermatitis discuss how patient preferences are taken into account when choosing between available treatments.

Patient preferences for atopic dermatitis treatments: a discrete ...

Conclusions: Patients with moderate-to-severe AD were willing to trade clinically relevant treatment risks for greater or more rapid itch reduction and skin ...

Patient preferences for atopic dermatitis medications in the UK ...

Topical betamethasone (29%) and hydrocortisone (24%) were the most frequent currently used individual medications. Most patients (68%) had no prior experience ...

Values and Preferences of Patients and Caregivers Regarding ...

Meaning In the first systematic review to address patient values and preferences in the management of atopic dermatitis to our knowledge, 6 key ...

Quantifying Patient Preferences for Systemic Atopic Dermatitis ...

Materials and Methods: Qualitative interviews were conducted with adults with moderate-to- severe AD (N = 21) to identify AD treatment ...

Patient Preferences in Atopic Dermatitis Treatment

Patients with moderate to severe AD gave their opinions in a survey on treatment options and their tradeoffs. Itch control topped the list ...

(PDF) Patients' preferences for systemic treatment of atopic dermatitis

The most severe cases of the disease require systemic treatment with immunosuppressants. Conclusions: The complex pathogenesis of atopic ...

Treatment Preference Research in Atopic Dermatitis: A Systematic ...

Treatment preference research can support shared and informed decision making for currently available atopic dermatitis (AD) treatments, and ...

Patients' preferences for systemic treatment of atopic dermatitis

Background: The advent of biologics and janus kinase inhibitors has revolutionized treatment of atopic dermatitis (AD).

PMU105 Patient Preferences for Systemic Atopic Dermatitis ...

The survey was completed by 404 patients (44.1±12.0 years of age; 65% female; 48% moderate AD (POEM score 8-16); 68% naïve to self-injectable treatments). The ...

Patient preferences for treatment attributes in moderate-to-severe ...

Atopic dermatitis (AD), also known as eczema, is a chronic, relapsing ... patient preferences regarding the different attributes of newer systemic therapies.

Investigating Patient Preferences for Atopic Dermatitis Treatment

Current management of AD consists of emollients and moisturizers, topical corticosteroids, and calcineurin inhibitors, with systemic ...

Understanding patient and physician preferences when choosing ...

A growing number of treatment options are becoming available for moderate-to-severe atopic dermatitis (AD), including biologic therapies. As ...